[1]聂冬辉,刘振昌,董金伟,等.六君子汤加减对老年中晚期肺癌化疗患者免疫功能的保护作用[J].西部中医药,2022,35(08):97-100.[doi:10.12174/j.issn.2096-9600.2022.08.23]
 NIE Donghui,LIU Zhenchang,DONG Jinwei,et al.Protective Effect of Modified Liujunzi Tang on Immunity in Elderly Patients with Advanced Lung Cancer Undergoing Chemotherapy[J].Western Journal of Traditional Chinese Medicine,2022,35(08):97-100.[doi:10.12174/j.issn.2096-9600.2022.08.23]
点击复制

六君子汤加减对老年中晚期肺癌化疗患者免疫功能的保护作用
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年08期
页码:
97-100
栏目:
临证经验
出版日期:
2022-08-15

文章信息/Info

Title:
Protective Effect of Modified Liujunzi Tang on Immunity in Elderly Patients with Advanced Lung Cancer Undergoing Chemotherapy
作者:
聂冬辉1 刘振昌1 董金伟1 李冬梅1 张锋利2
1.安徽中医药大学附属太和县中医院,安徽 阜阳 236600
2.安徽医科大学第一附属医院
Author(s):
NIE Donghui1 LIU Zhenchang1 DONG Jinwei1 LI Dongmei1 ZHANG Fengli2
1.Taihe County Hospital of TCM Affiliated to Anhui University of Chinese Medicine, Fuyang 236600, China
2.The First Affiliated Hospital of Anhui Medical University
关键词:
肺癌中晚期六君子汤免疫功能生活质量肿瘤标志物
Keywords:
lung cancer advancedimmunologic functionquality of lifetumor marker
分类号:
R734.2
DOI:
10.12174/j.issn.2096-9600.2022.08.23
摘要:
目的观察六君子汤加减对老年中晚期肺癌化疗患者免疫功能的保护作用。 方法选择老年中晚期肺癌患者80例,按照随机数字表法分为观察组和对照组,每组40例。对照组采用含铂两药化疗方案治疗,观察组在对照组治疗基础上服用六君子汤加减治疗,21天为1个周期,共治疗2个周期。检测两组患者治疗前后免疫功能指标:T淋巴细胞亚群CD3+、CD4+、CD8+,免疫球蛋白M(immunoglobulin M,IgM),免疫球蛋白G(immunoglobulin G,IgG),免疫球蛋白A(immunoglobulin A,IgA)水平;肿瘤标志物:细胞角蛋白十九片段(CYFRA21-1)、血清糖类抗原125(carbohydrate antigen 125,CA-125)、神经元特异性烯醇化酶(neuron specific enolase,NSE)、癌胚抗原(carcinoembryonic antigen,CEA)水平;采用肺癌患者生活质量测定量表(functional assessment of cancer therapy-lung,FACT-L)评价患者生活质量;统计疾病控制率和不良反应发生率。 结果治疗后,观察组CD3+、CD4+、CD4+/CD8+、IgA、IgG、IgM水平高于对照组(P<0.05),CD8+水平、CEA、AFG、CA125、NSE水平低于对照组(P<0.05)。观察组FACT-L评分高于对照组(P<0.05)。观察组疾病控制率[95.00%(38/40)]高于对照组[85.00%(34/40)](P<0.05)。观察组不良反应发生率[5.56%(3/54)]低于对照组[18.52%(10/54)](P<0.05)。 结论六君子汤加减治疗老年中晚期肺癌化疗患者,可保护患者免疫功能,降低肿瘤标志物水平,提升患者生活质量,疾病控制率,降低患者不良反应发生率。
Abstract:
ObjectiveTo observe protective effects of modified Liujunzi Tang on immunologic function in senile patients with advanced lung cancer undergoing chemotherapy. MethodsEighty patients were chosen, and divided into the observation group and the control group according to random number table method, with 40 cases in each group. The control group was treated with platinum-containing two-drug chemotherapy regimen, and the observation group took modified Liujunzi Tang based on chemotherapy regimen, 21 days were one cycle, both groups were treated for two cycles. To detect the indexes of immunologic function before and after treatment within two groups: the levels of T lymphocyte subsets CD3+, CD4+ and CD8+, IgM, IgG and IgA; and tumor markers: the levels of CYFRA21-1, CA-125, NSE and CEA; FACT-L was adopted to assess quality of life; to count disease control rate and the incidence of adverse reaction. ResultsAfter the treatment, the observation group was higher than the control group in the levels of CD3+, CD4+, CD4+/CD8+, IgA, IgG and IgM (P<0.05), lower than the control group in the levels of CD8+, CEA, AFG, CA125 and NSE (P<0.05). FACT-L scores of the observation group were higher than these of the control group (P<0.05). Disease control rate of the observation group was [95.00%(38/40)], higher than [85.00%(34/40)] of the control group (P<0.05). The incidence of adverse reaction of the observation group was [5.56%(3/54)], lower than [18.52%(10/54)] of the control group (P<0.05). ConclusionModified Liujunzi Tang in treating senile patients with advanced lung cancer undergoing chemoth-erapy could protect immunologic function, lower the levels of tumor markers, raise quality of life, disease control rate and reduce the incidence of adverse reaction.

相似文献/References:

[1]熊墨年,唐晓玲,余炅,等.益气清毒法联合化疗治疗中晚期胃癌的临床观察[J].西部中医药,2011,24(11):35.
[2]毛慧慧.温馨提示卡在肺癌患者健康教育中的应用及评价[J].西部中医药,2012,25(09):98.
 MAO Hui-hui.Evaluation and Application of Cue Card to Health Education of Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(08):98.
[3]张芳,孟宪明.培土生金法对气虚痰湿型肺癌化疗减毒增效的临床研究[J].西部中医药,2014,27(10):94.
[4]丁明明,吴勉华△.中药对肺癌细胞凋亡诱导基因表达的影响[J].西部中医药,2015,28(05):142.
[5]贡惠娟,赵玉娥,严春亚,等.循证护理对中晚期肺癌患者睡眠质量和自我护理能力的影响[J].西部中医药,2015,28(12):121.
[6]孟立峰,王军仓,王磊,等.麦味地黄丸防治肺癌放疗致放射性肺炎40例临床观察[J].西部中医药,2012,25(07):4.
 MENG Li-feng,WANG Jun-cang,WANG Lei,et al.Observation on MaiWei DiHuangWan in Preventing and Treating 40 Cases of Radiation Pneumonia Induced by Radiotherapy of Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(08):4.
[7]常云丽.心理护理干预对肺癌患者焦虑、抑郁等负性情绪的影响[J].西部中医药,2012,25(07):117.
 CHANG Yun-li.Influence of Psychological Nursing Intervention on Life Quality of Patients with Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(08):117.
[8]李静.穴位注射胃复安联合按压翳风穴对肺癌放化疗所致顽固性呃逆效果观察[J].西部中医药,2016,29(03):111.
 LI jing.Observation on Curative Effects of Acupoint Injection of Metoclopramide and Pressing YiFeng in Treating Intractable Hiccup induced by Radiotherapy and Chemotherapy Given to Lung Cancer Patients[J].Western Journal of Traditional Chinese Medicine,2016,29(08):111.
[9]倪军,顾惠英,冯高华.扶正抗瘤方对肺癌化疗患者细胞免疫功能及生活质量的影响[J].西部中医药,2014,27(12):6.
[10]徐玉娥,肖正国,宋薇,等.扶正升白口服液联合NP方案治疗晚期非小细胞肺癌的临床研究[J].西部中医药,2016,29(02):1.
 XU Yue,XIAO Zhengguo,SONG Wei,et al.Clinical Study on FuZheng ShengBai Oral Liquid Combined with NP Regimen in Treating Non Small-cell Lung Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2016,29(08):1.
[11]刘玉娟.综合护理干预对中晚期肺癌患者生活质量的影响[J].西部中医药,2018,31(03):116.
 LIU Yujuan.Effects of Comprehensive Nursing Intervention on Quality of Life of the Patients Suffering Lung Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2018,31(08):116.
[12]安青,吴燕波,李伟兵,等.补精解毒方联合化疗治疗老年中晚期非小细胞肺癌40例[J].西部中医药,2018,31(10):76.
 AN Qing,WU Yanbo,LI Weibing,et al.Essence-supplementing Detoxifying Prescription Combined with Chemotherapy in Treating 40 Senile Patients with Advanced Non Small-cell Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(08):76.

备注/Memo

备注/Memo:
聂冬辉(1983—),女,硕士学位,主治医师。研究方向:肿瘤的中西医结合治疗。
更新日期/Last Update: 2022-08-15